ArticleJournal of clinical immunology2003

Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.

C Arnold Spek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.